AgomAb Therapeutics N.V. American Depositary Shares (AGMB) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−8.9x

Market Cap

$777.13M

MomentumView details →

1D Return

+6.41%

YTD Return

—

RSI (14)

63.3

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−8.9x

Market Cap

$777.13M

RSI (14)

63.3

MomentumView details →

1D Return

+6.41%

YTD Return

—

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−47.78%

ROA (TTM)

−40.69%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

−1.59%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

−$0.91

EPS Surprise

−137.55%

Beats (12Q)

0/12

Next Q EPS Est

−$1.30

Avg Surprise (4Q)

−72.16%

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.01x

Current Ratio

6.52x

Quick Ratio

6.52x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

—

Op. CF (TTM)

—

Next earningsMar 3, 2027 →

Latest newsMore news →

No recent news for AGMB.

Similar companies

Crescent Biopharma, Inc.CBIO Neurogene Inc.NGNE Aura Biosciences, Inc.AURA Phathom Pharmaceuticals, Inc.PHAT Monopar Therapeutics Inc.MNPR Pharming Group N.V.PHAR Find similar companies →

Latest newsMore news →

No recent news for AGMB.